A Predictive Pharmacokinetic Model for Immune Cell-Mediated Uptake and Retention of Nanoparticles in Tumors

A promise of cancer nanomedicine is the “targeted” delivery of therapeutic agents to tumors by the rational design of nanostructured materials. During the past several decades, a realization that in vitro and in vivo preclinical data are unreliable predictors of successful clinical translation has m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sousa-Junior, Ailton, Yang, Chun-Ting, Korangath, Preethi, Ivkov, Robert, Bakuzis, Andris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779081/
https://www.ncbi.nlm.nih.gov/pubmed/36555306
http://dx.doi.org/10.3390/ijms232415664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779081/
https://www.ncbi.nlm.nih.gov/pubmed/36555306
http://dx.doi.org/10.3390/ijms232415664

Ejemplares similares